(6-Fluoro-2-methoxypyridin-3-yl)boronic acid, 98%, 5g

(1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl)methanol dihydrochloride, 95.0%, 250mg

S-Benzylglycidyl ether, 98.0%, 5g

4-Benzyloxyphenylacetic acid ethyl ester, 95.0%, 5g

4-Chloro-3-iodopyridin-2-amine, 98.0%, 25g

2-oxo-1,2,3,4-tetrahydro-6-quinolinesulfonyl chloride, 95.0%, 1g

Pipette tips 50-1200 μl, Box, 960 pieces, Non sterile, 960 pieces

4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-ol, 97.0%, 250mg

3-Ethoxy-5-(trifluoromethyl)phenol, 95%, 1g

2,2'-(9,9-Bis(6-bromohexyl)-9H -fluorene-2,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 98%, 250mg

(3-Chlorophenyl)(phenyl)methanamine hydrochloride, 98%, 1g

Methyl 3-bromo-5-hydroxybenzoate, 95.0%, 1g

6-ETHYNYLIMIDAZO[1,2-A]PYRAZINE, 95.0%, 250mg